Modalert 200 is an oral 'wakefulness-promoting' drug approved in the United Kingdom for the treatment of extreme drowsiness caused by narcolepsy with or without cataplexy.
Modafinil is not approved to treat tiredness in people with multiple sclerosis (MS), therefore this is an off-label usage of the drug.
At 8 weeks and 35 days, respectively, two small placebo-controlled randomized controlled trials (RCTs) found no statistically significant evidence that modafinil (up to 200 mg or 400 mg daily in the respective studies) relieved tiredness in persons with MS (of any disease pattern).
In both RCTs, no major side effects of modafinil were documented; nevertheless, typical side effects such as gastrointestinal problems and restlessness were detected. visit Pillspalace.com